China Jo-Jo Drugstores, Inc. (CJJD)
USD 1.82
(0.91%)
USD 1.82
(0.91%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -2.93 USD | 92.93% |
| 2023 | -41.46 USD | 81.21% |
| 2022 | -220.62 USD | -347.6% |
| 2021 | -49.29 USD | -4.36% |
| 2020 | -47.23 USD | -8487.27% |
| 2019 | -0.55 USD | 93.26% |
| 2018 | -8.16 USD | -142.86% |
| 2017 | -3.36 USD | -1033.33% |
| 2016 | 0.36 USD | -50.0% |
| 2015 | 0.72 USD | 103.28% |
| 2014 | -21.96 USD | -72.64% |
| 2013 | -12.72 USD | -276.67% |
| 2012 | 7.20 USD | -6.25% |
| 2011 | 7.68 USD | -41.28% |
| 2010 | 13.08 USD | 8275.0% |
| 2009 | -0.16 USD | -367.84% |
| 2008 | -0.03 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q4 | -0.98 USD | 0.0% |
| 2024 Q2 | -0.39 USD | 0.0% |
| 2024 FY | - USD | 92.93% |
| 2024 Q3 | -0.98 USD | -151.28% |
| 2024 Q1 | -0.39 USD | 96.99% |
| 2023 Q2 | -1.31 USD | 0.0% |
| 2023 Q1 | -1.31 USD | 99.35% |
| 2023 Q3 | -12.95 USD | -888.55% |
| 2023 Q4 | -12.95 USD | 0.0% |
| 2023 FY | - USD | 81.21% |
| 2022 Q2 | -1.51 USD | -25.83% |
| 2022 Q3 | -8.42 USD | -457.62% |
| 2022 Q4 | -202.07 USD | -2299.88% |
| 2022 Q1 | -1.20 USD | -2410.46% |
| 2022 FY | - USD | -347.6% |
| 2021 FY | - USD | -4.36% |
| 2021 Q1 | -0.14 USD | 87.16% |
| 2021 Q3 | -1.83 USD | -273.47% |
| 2021 Q4 | -0.05 USD | 97.39% |
| 2021 Q2 | -0.49 USD | -250.0% |
| 2020 FY | - USD | -8487.27% |
| 2020 Q4 | -1.09 USD | -554.17% |
| 2020 Q3 | 0.24 USD | 153.33% |
| 2020 Q2 | -0.45 USD | 43.04% |
| 2020 Q1 | -0.79 USD | -159.85% |
| 2019 Q4 | 1.32 USD | 283.33% |
| 2019 Q2 | -0.66 USD | -144.44% |
| 2019 FY | - USD | 93.26% |
| 2019 Q3 | -0.72 USD | -9.09% |
| 2019 Q1 | -0.27 USD | 95.57% |
| 2018 Q2 | -0.56 USD | 17.65% |
| 2018 FY | - USD | -142.86% |
| 2018 Q1 | -0.68 USD | 73.54% |
| 2018 Q3 | -0.77 USD | -37.5% |
| 2018 Q4 | -6.10 USD | -692.21% |
| 2017 Q3 | -0.50 USD | -516.67% |
| 2017 FY | - USD | -1033.33% |
| 2017 Q4 | -2.57 USD | -414.0% |
| 2017 Q2 | 0.12 USD | 0.0% |
| 2017 Q1 | 0.12 USD | -80.0% |
| 2016 Q4 | 0.60 USD | 239.53% |
| 2016 Q2 | 0.12 USD | 0.0% |
| 2016 Q3 | -0.43 USD | -458.33% |
| 2016 FY | - USD | -50.0% |
| 2016 Q1 | 0.12 USD | -87.5% |
| 2015 Q4 | 0.96 USD | 700.0% |
| 2015 Q2 | -0.03 USD | 90.0% |
| 2015 Q1 | -0.29 USD | 97.75% |
| 2015 FY | - USD | 103.28% |
| 2015 Q3 | 0.12 USD | 513.79% |
| 2014 Q2 | -0.48 USD | 33.33% |
| 2014 Q3 | -7.68 USD | -1500.0% |
| 2014 Q4 | -12.88 USD | -67.71% |
| 2014 Q1 | -0.72 USD | 91.77% |
| 2014 FY | - USD | -72.64% |
| 2013 Q2 | -1.35 USD | -381.25% |
| 2013 Q4 | -8.75 USD | -180.45% |
| 2013 Q3 | -3.12 USD | -131.11% |
| 2013 Q1 | 0.48 USD | -66.67% |
| 2013 FY | - USD | -276.67% |
| 2012 Q4 | 1.44 USD | 0.0% |
| 2012 FY | - USD | -6.25% |
| 2012 Q3 | 1.44 USD | 0.0% |
| 2012 Q2 | 1.44 USD | -50.0% |
| 2012 Q1 | 2.88 USD | 33.33% |
| 2011 Q1 | 2.04 USD | -58.54% |
| 2011 Q4 | 2.16 USD | 5.88% |
| 2011 Q3 | 2.04 USD | 41.67% |
| 2011 FY | - USD | -41.28% |
| 2011 Q2 | 1.44 USD | -29.41% |
| 2010 FY | - USD | 8275.0% |
| 2010 Q4 | 4.92 USD | 57.69% |
| 2010 Q2 | 2.40 USD | 35720.9% |
| 2010 Q3 | 3.12 USD | 30.0% |
| 2010 Q1 | 0.01 USD | 127.57% |
| 2009 Q4 | -0.02 USD | 22.61% |
| 2009 Q1 | -0.02 USD | 76.17% |
| 2009 Q3 | -0.03 USD | -383.08% |
| 2009 FY | - USD | -367.84% |
| 2009 Q2 | -0.01 USD | 71.62% |
| 2008 Q2 | -0.00 USD | 0.0% |
| 2008 Q4 | -0.10 USD | -137.28% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | -0.04 USD | -726.53% |
| Name | Eps | Eps Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -52.60 USD | 94.43% |
| BIMI International Medical Inc. | -8.40 USD | 65.119% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | -0.75 USD | -290.667% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | -0.75 USD | -290.667% |
| Leafly Holdings, Inc. | -4.74 USD | 38.186% |
| Leafly Holdings, Inc. | -4.74 USD | 38.186% |
| LifeMD, Inc. | -0.70 USD | -318.571% |
| LifeMD, Inc. | -0.70 USD | -318.571% |
| TRxADE HEALTH, Inc. | -23.35 USD | 87.452% |
| PetMed Express, Inc. | -0.37 USD | -691.892% |
| Walgreens Boots Alliance, Inc. | -10.01 USD | 70.729% |